Medical Science LiaisonRoche Pharma Schweiz AG, Basel, SwitzerlandBasel, Basel-Stadt, Switzerland
OC 43.4 - Effectiveness of emicizumab under real-world conditions in patients of all ages with hemophilia A with and without FVIII inhibitors: interim analysis of the non-interventional study EMIIL
Monday, June 26, 202315:30 – 15:45 ET